Non-prescription therapeutics for IBS: where are we?

30 Jan 2024

by Andrea Costantino

Alterations in the gut microbiome composition and functions are emerging as a potential target for managing IBS. Discover how microbiota-modifying treatments, including prebiotics, probiotics, antibiotics, and fecal microbiota transplantation, hold promise in alleviating symptoms of this vexing condition.

As we look back, we can certainly say that 2021 has been a productive year for gut microbiome research. In this last post of the year, we bring you key articles from our blog and studies on major advances in the role of the gut microbiome in maintaining health and helping to manage gut and immune-related diseases. We will also look at the therapeutic potential of probiotics, prebiotics and postbiotics for your clinical practice.

Beyond live microorganisms, inanimate microorganisms and their components can also confer a health benefit on the host. A panel of experts under the auspices of the International Scientific Association for Probiotics and Prebiotics (ISAPP) updates the definition and scope of postbiotics.

Irritable bowel syndrome is one of the most common disorders diagnosed by gastroenterologists. Peppermint oil, specific probiotics, psyllium supplementation, first-line IBS dietary advice, and a low FODMAP diet can aid in improving IBS symptoms.

Fermented foods are a known source of lactic acid bacteria. A high-throughput sequencing analysis of food and human metagenomes proves that fermented foods are a source of lactic acid bacteria for the gut microbiome, and that abundance is shaped by both age and lifestyle.

Go to Top